Barclays Upgrades GlaxoSmithKline (GSK) to Overweight

January 29, 2013 9:10 AM EST
Get Alerts GSK Hot Sheet
Price: $45.18 +0.13%

Rating Summary:
    5 Buy, 10 Hold, 3 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 16 | Down: 26 | New: 7
Trade GSK Now!
Join SI Premium – FREE
Barclays upgraded GlaxoSmithKline (NYSE: GSK) from Equalweight to Overweight.

For an analyst ratings summary and ratings history on GlaxoSmithKline click here. For more ratings news on GlaxoSmithKline click here.

Shares of GlaxoSmithKline closed at $44.56 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Upgrades

Related Entities

Barclays

Add Your Comment